AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2018
Aug 2, 2018
35086_dirs_2018-08-02_0887b409-a140-4b66-9b1f-1b226a6ed290.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2018-08-01
Reporting Person: Smith Devin Whittemore (SVP and General Counsel)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-01 | Employee Stock Option (Righ to Buy) | $7.95 | A | 200000 | Acquired | 2028-08-01 | Common Stock (200000) | Direct |
Footnotes
F1: This option vests as to 25% of the shares on July 23, 2019 and then in quarterly installments over 3 years thereafter.
More from Minerva Neurosciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Capital/Financing Update
2026
May 27
Share Issue/Capital Change
2026
May 27
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17